Inhibition of murine sarcoma virus oncogenesis with living BCG.
D000818:Animals; D000970:Antineoplastic Agents; D001500:BCG Vaccine / Q000627:therapeutic use; D001681:Biological Assay; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic / Q000276:immunology; D003470:Culture Media; D046508:Culture Techniques; D006614:Hindlimb; D007114:Immunization; D051379:Mice; D008979:Moloney murine leukemia virus / Q000254:growth & development* / Q000472:pathogenicity; D009163:Mycobacterium bovis / Q000276:immunology*; D009365:Neoplasm Regression, Spontaneous; D011379:Prognosis; D012513:Sarcoma, Experimental / Q000276:immunology / Q000503:physiopathology
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D003470:Culture Media